SBI Life Insurance Company Ltd
- P/E
- 63x
- 52-week range
- 1,607.7 – 2,132
- ROE
- 14%
- ROCE
- 15%
- Sector
- Insurance
- Industry
- Life Insurance
- Listed on
- NSE, BSE
About
SBI Life Insurance Company Limited is an India-based company which offers life insurance plans and policies. The Company operates through three segments: Participating, Non-Participating, and Linked segments. Its Participating life insurance products are savings-oriented protection plans where policyholders are entitled to a share in the surplus generated from the participating segment during the term of the policy contract. Its Participating segment's products include Individual Life, Individual Pension, Group Pension, and Variable Insurance. The Non-Participating segment comprises individual savings, group savings and protection segments. These product offerings provide defined benefits over a fixed period and do not entitle the insured to a share in the fund surplus. Its Linked products offer a combination of insurance protection and market-linked investment opportunities, and the returns are directly linked to the performance of the underlying funds.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Life Insurance: 6 companies →SBI Life Insurance Company Ltd against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)63 against a typical 58.8: pricier than most peers (1st = cheapest).4th of 6
- Sales growth+18.8% against a typical +12.8% from a year earlier.1st of 6
- Profit growth+22.1% against a typical +23% from a year earlier.4th of 6
- Share price, 3 months−12% against a typical −14%.3rd of 6
Latest announcements
Exchange filings and their impact on the company.
- SBI Life approved Q2/H1 results with a clean review and proposed an independent director appointment, with no disclosed financial surprise.
SBI Life's board on October 27, 2026 approved its unaudited results for the quarter and half year ended September 30, 2026, with joint auditors giving an unmodified limited review. The board also agreed to seek shareholder approval by postal ballot for appointing Mr. Nihar Niranjan Jambusaria as an independent director, with e-voting from November 4 to December 3, 2026. With no result figures disclosed in the extracted text, there is no quantifiable surprise for the business.
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Highest safety
Rated AAA by CRISIL- No warnings from the agency.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CRISIL | Crisil AAA | Stable | 4 May 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 4 May 2026 | Reaffirmed | Crisil AAA | — | CRISIL | — |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 27 Oct 2026 | Financial Results | To consider and approve the financial results for the period ended September 30, 2026 |
| 24 Jul 2026 | Financial Results | To consider and approve the financial results for the period ended June 30, 2026 |
| 22 Apr 2026 | Financial Results | To consider and approve the financial results for the period ended March 31, 2026 |
| 25 Feb 2026 | Dividend | To consider dividend |
| 28 Jan 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 24 Oct 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 28,805 | 39,033 | 36,255 | 34,654 | 40,302 | 18,862 | 23,071 | 38,996 | 23,115 | 46,133 | 4,071 | 46,337 |
| Expenses | 28,392 | 38,681 | 37,043 | 34,060 | 39,696 | 18,266 | 23,520 | 38,333 | 22,600 | 45,517 | 5,117 | 45,579 |
| Operating Profit | 413 | 352 | −788 | 594 | 606 | 596 | −449 | 664 | 516 | 615 | −1,046 | 757 |
| OPM % | 1.4% | 0.9% | −2.2% | 1.7% | 1.5% | 3.2% | −1.9% | 1.7% | 2.2% | 1.3% | −26% | 1.6% |
| Other Income | 12 | 18 | 1,639 | 3 | −4 | −3 | 1,350 | −8 | 16 | 27 | 1,913 | 36 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 424 | 370 | 851 | 597 | 601 | 594 | 901 | 656 | 532 | 642 | 867 | 793 |
| Tax % | 10% | 13% | 5% | 13% | 12% | 7% | 10% | 9% | 7% | 10% | 7% | 9% |
| Net Profit | 380 | 322 | 811 | 520 | 529 | 551 | 814 | 594 | 495 | 577 | 805 | 725 |
| EPS in Rs | 3.8 | 3.21 | 8.1 | 5.19 | 5.28 | 5.5 | 8.12 | 5.93 | 4.93 | 5.75 | 8.02 | 7.23 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 19%
- 5 Years
- 7%
- 3 Years
- 12%
- TTM
- −1%
- 10 Years
- 11%
- 5 Years
- 11%
- 3 Years
- 13%
- TTM
- 5%
- 10 Years
- —
- 5 Years
- 10%
- 3 Years
- 12%
- TTM
- —
- 10 Years
- 15%
- 5 Years
- 14%
- 3 Years
- 14%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| SBI Life Insurance Company Ltd | ₹ 1,666.70 | — | 63x | — | 14% | — |
| Life Insurance Corporation of India | ₹ 380.35 | ₹ 4,81,143 Cr. | 9.2x | 2.9x | 0% | 0% |
| Bajaj Finserv | ₹ 1,656.00 | ₹ 2,65,301 Cr. | 18.1x | 3.9x | 0% | 0% |
| HDFC Life Insurance Company | ₹ 523.50 | ₹ 1,13,735 Cr. | 59x | 6.4x | 0% | 0% |
| Aditya Birla Capital | ₹ 346.75 | ₹ 94,929 Cr. | 20.7x | 3x | 0% | 0% |
| General Insurance Corporation of India | ₹ 323.80 | ₹ 56,840 Cr. | 6.3x | 1x | 0% | 0% |
Management
- Sangramjit Sarangi
- President, Chief Financial Officer
- M. Anand
- President and Chief Distribution Officer
- Amit Jhingran
- Chief Executive Officer, Managing Director, Executive Director
- Girish Mahesh Manik
- Company Secretary
Prices are delayed and for information only. Nothing on this page is investment advice.